Market open · Delayed intraday data · 2:15 PM ET
Last update: Jun 30, 2026, 2:04 PM ET
Abbott Laboratories (ABT) — What Changed
$91.40-1.31 (-1.41%) today so far
Jun 30, 2026 2:16 PM ET·New York Stock Exchange·Market Open·CEO: Robert Ford·114,000 employees
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of h…
🔔Material Change Detected
Price Move
-1.41%
1-Day Change
Volume Confirmation
0.27x
vs 30D Average
Catalyst
Filings
Filings
Peer Context
Outperforming
Top 2 of 6 peers
Signal Quality
Low
Confidence Score
45/100
BestStocks surfaces only meaningful changes—backed by price, volume, catalysts, and peer context—so you can focus on what matters.
1. What Changed Since Last Close
V›
Price Move UpLowLow
Jun 26+0.94%0.94x vol
Abbott Laboratories moved +0.94% from $93.24 to $94.12 on 2026-06-26, reaching a new 30-day high. We checked news, earni
V›
Price Move UpMediumMedium
Jun 25+3.04%0.96x vol
Abbott Laboratories moved +3.04% from $90.49 to $93.24 on 2026-06-25, reaching a new 30-day high. We checked news, earni
F›
New FilingHighHigh
Apr 29
Abbott Laboratories (ABT) filed its 10-Q quarterly report on 2026-04-29, with no immediate price movement recorded as of
Showing 3 of 3 events
2. Change Timeline
| Date | Change | Price Reaction | Volume | Confidence ↓ |
|---|---|---|---|---|
| Apr 29 | FNew Filing | — | — | High |
| Jun 25 | VPrice Move Up | +3.04% | 0.96x | Medium |
| Jun 26 | VPrice Move Up | +0.94% | 0.94x | Low |
Sort:
3. Why It Moved
1
Primary Catalyst
Filings
Abbott Laboratories (ABT) filed its 10-Q quarterly report on 2026-04-29, with no
2
Supporting Evidence
- Abbott Laboratories moved +3.04% from $90.49 to $93.24 on 2026-06-25,
- Abbott Laboratories moved +0.94% from $93.24 to $94.12 on 2026-06-26,
3
Nature of Move
Company-Specific Move
ABT outperformed peers by more than expected sector variance — move appears company-specific.
4. Peer / Sector Confirmation
| Symbol | Today | 5D | Rel. Vol | |
|---|---|---|---|---|
| ABT | -1.41% | — | 0.27x | Leader |
| LLY | +1.81% | — | — | |
| UNH | -1.89% | — | — | |
| JNJ | +1.51% | — | — | |
| PFE | +0.33% | — | — | |
| ABBV | +0.38% | — | — |
Company-Specific Move. Top 2 of 6 peers. ABT outperformed peers by more than expected sector variance — move appears company-specific.
5. SEC Filing Watch
Apr 29Medium
Quarterly financial results
Apr 27High
Material event — review for impact
Apr 17High
Material event — review for impact
Apr 16High
Material event — review for impact
Mar 23High
Material event — review for impact
Mar 13Low
Annual proxy — exec compensation & governance
Mar 9High
Material event — review for impact
View on SEC EDGAR →Source: filing_snapshots DB · past 120 days
6. Analyst Expectations
Consensus Target
$126.00
Median Target
$123.50
Upside to Target
+37.9%
vs $91.40
Analyst Activity — Last 90 Days
0
Upgrades
14
Maintains
0
Downgrades
Last Directional Actions
↑ Upgrade
Freedom Broker · Hold → Buy
Jan 29, 2026
↓ Downgrade
Guggenheim Securities · Buy → Neutral
Jan 2, 2020
7. Bull vs Bear Thesis Shift
Bullish Factors
✓Abbott Laboratories moved +3.04% from $90.49 to $93.24 on 20
✓Abbott Laboratories moved +0.94% from $93.24 to $94.12 on 20
Bearish Factors
✕Negative session, down 1.4%
✕New SEC filing — review for material disclosures
Net Thesis Change vs Yesterday
BearishNeutralBullish
Neutral / Mixed-3 / 100
8. What To Watch Next
| Date | Event | Impact | |
|---|---|---|---|
| Jul 16 | Earnings Release | High | |
| Jul 29est. | 10-Q Filing | Medium |
est. = estimated from prior filing cycle
🔔
9. Set Alerts & Get Notified
Get notified when ABT reports earnings, files an 8-K, receives an analyst upgrade, or sees unusual volume.
✓ Earnings alerts
✓ Filing alerts
✓ Volume spikes
✓ Analyst actions